FTC sues significant pharmacy reward supervisors more than insulin selling prices The agency brought action versus Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the record price of daily life-conserving insulin prescription drugs. Sanders swiftly condemned the transfer in a statement Wednesday, noting https://kethek.com/